A Comprehensive Board Review in Hematology and Medical Oncology

1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.
2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
3. Demonstrate proficiency of knowledge in hematology and medical oncology.
4. Incorporate recent advances in management of hematologic and oncologic patients.

A Virtual Live Streaming Course

The Comprehensive Board Review in Hematology and Medical Oncology will be virtual. This program will be presented only as a live streaming course.

PLANNING COMMITTEE
MD Anderson Cancer Center
Sharon Giordano, MD, MPH, Co-Director
Tapan Kadia, MD, Co-Director
Shreyaskumar Patel, MD
Alessandra Ferrajoli, MD
Nishin Bhadka, MD
Felisha Estelle

Baylor College of Medicine
Martha Mims, MD, PhD, Co-Director

PRESENTATIONS
Course syllabus will not be printed. Presentations (slides) will be available online via the course platform and Canvas. The PowerPoint presentations will be posted online as PDFs prior to the conference. You will receive an invitation email with directives to log in Canvas.

• The Full Conference and Hematology Session will begin at 7:30 a.m. on Monday, September 15.  The Hematology Session will adjourn at 5:15 p.m. on Wednesday, September 17. The full conference will adjourn at 5:10 p.m. on Saturday, September 20.

• The Oncology Session will begin at 12:30 p.m. on Tuesday, September 16 and adjourn at 5:10 p.m. on Saturday, September 20.

Advanced registration is encouraged.  Please see the registration fees below.

*NOTE: The conference registration fee includes the tuition, access to course virtual platform with PDFs of the slides and Canvas - online web-based system with recorded videos.

The early bird registration deadline is Monday, July 21, 2025.

Telephone registrations are not accepted.

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check (payable through U.S. banks only)

• Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

REFUND/CANCELLATION POLICY
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Monday, August 25, 2025.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity by emailing Continuing Professional Education at [email protected]. All responses will be forwarded to the Program Directors for consideration.

EVALUATION
An online course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

SPECIAL ASSISTANCE
Contact Felisha Estelle in Continuing Professional Education at 713-745-0083 or 1-866-531-MOBR (6627) if you have any ADA accommodation needs.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

American Board of Internal Medicine (ABIM)
Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to 50.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CE credits claimed for the activity. It is the CE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf. 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Sharon H. Giordano, MD, FASCO
Professor
The University of Texas MD Anderson Cancer Center

Co-Director, Faculty

Nothing to disclose

Tapan M. Kadia, MD
Professor
The University of Texas MD Anderson Cancer Center

Co-Director, Faculty

Grant or research support-Bristol-Myers Squibb Company|Honoraria-DAVA Oncology|Speakers Bureau-CURE|Honoraria-DrenBio|Grant or research support-Dren Bio|Grant or research support-Celgene Corporation (Relationship has ended)|Grant or research support-BMS|Honoraria-Biologix (Relationship has ended)|Grant or research support-Janssen Biotech, Inc. (Relationship has ended)|Grant or research support-Incyte Corporation|Grant or research support-Astex|Grant or research support-Abcuro|Grant or research support-Pfizer Inc.|Honoraria-Hikma Pharmaceuticals|Consulting Fee-Genzyme Corporation (Relationship has ended)|Grant or research support-Glycomimetics|Consulting Fee-Sellas|Grant or research support-Sellas|Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc. (Relationship has ended)|Grant or research support-Genentech, Inc.|Grant or research support-Ascentage|Grant or research support-Cellenkos (Relationship has ended)|Grant or research support-AstraZeneca US (Relationship has ended)|Grant or research support-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Paid consultant-AbbVie Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Genfleet|Grant or research support-Sellas, Inc|Grant or research support-Delta Fly Pharma (Relationship has ended)|Grant or research support-Jazz Pharmaceuticals|Paid consultant-Jazz Pharmaceuticals|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Agios Pharmaceuticals Inc.|Consulting Fee-PinotBio (Relationship has ended)|Consulting Fee-Sanofi US (Relationship has ended)|Paid consultant-Pfizer Inc.|Grant or research support-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Servier Pharmaceuticals|Consulting Fee-Syndax|Consulting Fee-Kura

Martha Mims, MD, PhD
Professor and Section Chief, Hematology/Oncology
Baylor College of Medicine

Co-Director, Faculty

Stocks or stock options, excluding diversified mutual funds-Amgen Inc.|Stocks or stock options, excluding diversified mutual funds-Biogen Inc.|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Celgene Corporation|Grant or research support-Incyte Corporation|Grant or research support-inovio

Neal S. Akhave, MD
Head and Neck Medical Oncologist
MD Anderson Cancer Center

Faculty

Rodabe N. Amaria, MD
Associate Professor, Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-KSQ|Grant or research support-Erasca|Grant or research support-Erasca|Consulting Fee-Obsidian |Grant or research support-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Grant or research support-Regeneron Pharmaceuticals, Inc.|Grant or research support-Iovance (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Obsidian|Grant or research support-OnKure|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-TIL Working Group|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Nektar (Relationship has ended)

Kenneth Bauer, MD, Physician
Professor
Beth Israel Deaconess Medical Center

Faculty

Nancy Berliner, MD
Chief, Division of Hematology
Brigham and Women's Hospital

Faculty

Abenaa M. Brewster, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Bradley Carthon, MD, PhD, MD, PhD
Associate Professor
Emory Healthcare

Faculty

Carla Casulo, MD
University of Rochester

Faculty

Mariana C. Chavez MacGregor, MD, Associate Profesor
Associate Professor
The University of Texas MD Anderson Cancer Center

Faculty

Kelly S. Chien, MD
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Jorge Cortes, MD
Director
Georgia Cancer Center at Augusta University

Faculty

Courtney D. DiNardo, MD
Associate Professor
The University of Texas MD Anderson Cancer Center

Faculty

Ravin J. Garg, MD
Medical Doctor
Maryland Oncology Hematology/US Oncology and Assistant Professor of Oncology/Johns Hopkins Hospital

Faculty

Carl M. Gay, MD
The University of Texas MD Anderson Cancer Center

Faculty

Timothy D. Gilligan, MD, FASCO, FACH
Associate Professor & Vice-Chair for Education
Cleveland Clinic Taussig Cancer Institute

Faculty

Nothing to disclose

Betty Hamilton, MD
Cleveland Clinic

Faculty

Nasser H. Hanna, MD
Professor of Medicine
Indiana University

Faculty

Yvonne J. Heung, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Emily Hinchcliff, MD
Assistant Professor
Northwestern Medicine

Faculty

Mimi I. Hu, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Claudine Isaacs, MD, FRCPC
Professor
Georgetown

Faculty

Eric Jonasch, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Consulting Fee-Aveo|Grant or research support-ProFoundBio|Grant or research support-AbbVie Inc.|Grant or research support-Telix|Grant or research support-Aveo|Grant or research support-Corvus|Consulting Fee-Aravive (Relationship has ended)|Grant or research support-Arrowhead|Consulting Fee-Eisai, Inc.|Honoraria-Exelixis|Honoraria-Ipsen US|Honoraria-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation|Honoraria-Nikang|Grant or research support-Nikang|Honoraria-Takeda (Relationship has ended)|Honoraria-DAVA

Hagop M. Kantarjian, MD
Chair, Leukemia
The University of Texas MD Anderson Cancer Center

Faculty

Edmund S. Kopetz, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Alfred Lee, MD, PhD
Yale School of Medicine

Faculty

Mark Lewis, MD
Intermountain Healthcare

Faculty

Whitney Lewis, PharmD
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center

Faculty

Jennifer K. Litton, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Pfizer Inc. (Relationship has ended)|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants (Relationship has ended)|Grant or research support-Zenith (Relationship has ended)|Grant or research support-AstraZeneca US (Relationship has ended)|Grant or research support-EMD Serono Inc. (Relationship has ended)|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-Genentech, Inc. (Relationship has ended)|Speakers Bureau-Clinical Care Options|Royalties or Patent Beneficiary-Certis|Speakers Bureau-tumorboardtues (Relationship has ended)

Alice Ma, MD
Professor of Medicine
University of North Carolina

Faculty

Leonard Medeiros, MD
Chair - Hematopathology Adm
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Stephan Moll, MD
UNC Chapel Hill

Faculty

Alison Moskowitz, MD
Memorial Sloan Kettering Cancer Center

Faculty

Kerry O'Brien, MD
Medical Director Blood Bank
Beth Israel Deaconess Medical Center

Faculty

Susan O'Brien, MD
Professor of Medicine
University of California Irvine

Faculty

Timothy Olson, MD, PhD
Medical Director, Blood and Marrow Transplant Program
Children's Hospital of Philadelphia

Faculty

Antonio Omuro, MD
Stanford University

Faculty

Jacquelyn Powers, MD

Faculty

S. Vincent Rajkumar, MD
Professor of Medicine
Mayo Clinic

Faculty

Raajit Rampal, MD, PhD
Associate Member
MSKCC

Faculty

A. Koneti Rao, MD
Lewis Katz School of Medicine

Faculty

Jose A. Rauh-Hain, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Caitlin R Rausch, PharmD, BCOP
Clinical Pharmacy Specialist
MD Anderson Cancer Center

Faculty

Bethany T Samuelson Bannow, MD, MCR
Associate Professor
Oregon Health & Science University

Faculty

Samuel A. Shelburne III, MD, Fellow Infectious Diseases Society of America
Professor, Infectious Diseases
The University of Texas MD Anderson Cancer Center

Faculty

Arlene O. Siefker-Radtke, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Gerald A Soff, MD
Chief, Classical Hematology Service
University of Miami Health System/Sylvester Comprehensive Cancer Center

Faculty

Paolo Strati, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Senthil Sukumar, MD
Baylor College of Medicine

Faculty

Jason R. Westin, MD
Dr
MDACC

Faculty

William N. William Jr., MD
Medical Oncologist
Hospital BP
Brazil

Faculty

Robert A. Wolff, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Harry H. Yoon, MD
Associate Professor
Mayo Clinic

Faculty

Felisha Estelle, BBA
CE Activity Planner
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Shreyaskumar Patel, MD
Professor - Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Deciphera|Consulting Fee-Kura Oncology

Nishin Bhadkamkar, MD
Associate Professor
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Alessandra Ferrajoli, MD
Professor of Medicine
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Membership on Advisory Committees or Review Panels, Board Membership, etc.-AbbVie Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US (Relationship has ended)